The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma.
Singh, Sundeep
The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma. [electronic resource] - Digestive diseases and sciences Aug 2011 - 2491-6 p. digital
Publication Type: Journal Article
1573-2568
10.1007/s10620-011-1709-8 doi
Adenoma--diagnosis
Bile Duct Neoplasms--blood
Bile Ducts, Intrahepatic
Biomarkers, Tumor--blood
CA-19-9 Antigen--blood
Cholangiocarcinoma--blood
Choledocholithiasis--blood
Cholestasis--blood
Female
Humans
Jaundice--blood
Male
Pancreatic Neoplasms--blood
ROC Curve
Retrospective Studies
Sensitivity and Specificity
The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma. [electronic resource] - Digestive diseases and sciences Aug 2011 - 2491-6 p. digital
Publication Type: Journal Article
1573-2568
10.1007/s10620-011-1709-8 doi
Adenoma--diagnosis
Bile Duct Neoplasms--blood
Bile Ducts, Intrahepatic
Biomarkers, Tumor--blood
CA-19-9 Antigen--blood
Cholangiocarcinoma--blood
Choledocholithiasis--blood
Cholestasis--blood
Female
Humans
Jaundice--blood
Male
Pancreatic Neoplasms--blood
ROC Curve
Retrospective Studies
Sensitivity and Specificity